Richard Levy
Pediatric Endocrinology · Chicago, ILNPI 1265431381
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,481 of the $14,439 with a category attached, or 65.7%. Neurocrine Biosciences, Inc. accounts for 65.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $6,542 and has fallen 71.4% since, to $1,868 in 2025.
Across 76 payments — averaging $189.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$9K
- Amgen$2K
- Sandoz$2K
- Novo Nordisk$465
- AstraZeneca$242
- Sanofi-aventis U.S. LLC$147
- plus $483 from 14 others
Across 1 payment — averaging $375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche Diabetes Care, Inc.$375
What the payments were for
- Consulting fees$9,48166%
- Speaking & faculty fees$3,31223%
- Food & beverage$1,58311%
- Education$640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 4 | $9,481 |
| Amgen | 9 | $2,110 |
| Sandoz | 4 | $1,512 |
| Novo Nordisk | 29 | $465 |
| AstraZeneca | 6 | $242 |
| Sanofi-aventis U.S. LLC | 2 | $147 |
| Exelixis Inc. | 1 | $108 |
| Amryt Pharma Holdings Ltd | 4 | $66 |
| Bayer | 3 | $63 |
| Boehringer Ingelheim | 3 | $52 |
| Lilly USA, LLC | 2 | $37 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Vistapharm, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Insulet Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,439 in reported general payments places this provider in the 85th percentile of 61 pediatric endocrinology providers in Illinois.
Other pediatric endocrinology in Chicago
- Anita SwamyChicago$1.4M
- Courtney FinlaysonChicago$46K
- Stelios MantisChicago$27K
- Reema HabibyChicago$13K
- Siri Atma GreeleyChicago$13K
- Jennifer MillerChicago$8K
- Jill SamisChicago$7K
- Claudia Boucher BerryChicago$4K
- Naomi FogelChicago$3K
- Sylvia RobinsonChicago$662
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.